SCN2A Gene

HGNC Family Ion channels
Name sodium channel, voltage gated, type II alpha subunit
Description Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSCN2A encodes the neuronal voltage‐gated sodium channel α subunit, NaV1.2, which is essential for the initiation and propagation of action potentials in the central nervous system. Structural studies using high‐resolution cryo–electron microscopy and NMR have delineated its modular architecture—including multiple transmembrane segments and a conserved C–terminal domain that interacts with calcium–bound calmodulin—to explain how ion permeation and gating are precisely controlled. Moreover, regulatory mechanisms such as alternative splicing, sialylation, and interactions with auxiliary β subunits and fibroblast growth factors serve to fine–tune channel kinetics in a developmentally regulated manner, with distinct isoforms expressed in neonatal versus adult neurons."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wide spectrum of mutations in SCN2A—ranging from missense to nonsense and frameshift variants—has been identified in patients with diverse neurodevelopmental disorders. These mutations disrupt the normal gating properties of NaV1.2 by producing either gain–of–function effects (such as increased persistent sodium current, slowed inactivation, or depolarized shifts in voltage–dependent gating) or loss–of–function changes that reduce channel activity. Such perturbations underlie a broad range of clinical phenotypes, including benign familial neonatal–infantile seizures, severe epileptic encephalopathies, autism spectrum disorders, intellectual disability, and episodic ataxia. Importantly, the effects of these mutations can be modulated by developmentally regulated splicing and cell–specific regulatory machinery, further influencing neuronal excitability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nElectrophysiological and pharmacological studies of SCN2A variants have advanced our understanding of the genotype–phenotype correlations that determine therapeutic responsiveness. Investigations have revealed that factors such as alternative splicing, interaction with regulatory proteins, post–translational modifications, and even temperature–dependent kinetics can significantly influence channel function. These insights are being leveraged to tailor treatment strategies—such as the use of sodium channel blockers—in a precision medicine framework for patients with SCN2A–related syndromes. Furthermore, emerging data on genetic modifiers and ion channel anchoring emphasize the complex regulation of NaV1.2 and underscore its importance as a test case for elucidating the neurobiology of epilepsy and other neurodevelopmental disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "45"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "K Haug, K Hallmann, J Rebstock, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The voltage-gated sodium channel gene SCN2A and idiopathic generalized epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsy Res (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0920-1211(01)00312-6"}], "href": "https://doi.org/10.1016/s0920-1211(01"}, {"type": "t", "text": "00312-6) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11738931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11738931"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "L A Weiss, A Escayg, J A Kearney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium channels SCN1A, SCN2A and SCN3A in familial autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4001241"}], "href": "https://doi.org/10.1038/sj.mp.4001241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12610651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12610651"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kazusaku Kamiya, Makoto Kaneda, Takashi Sugawara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3089-03.2004"}], "href": "https://doi.org/10.1523/JNEUROSCI.3089-03.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15028761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15028761"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "James Kim, Smita Ghosh, Huajun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calmodulin mediates Ca2+ sensitivity of sodium channels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M407286200"}], "href": "https://doi.org/10.1074/jbc.M407286200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15316014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15316014"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Oleksandr Platoshyn, Carmelle V Remillard, Ivana Fantozzi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of functional voltage-gated Na(+) channels in cultured human pulmonary artery smooth muscle cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pflugers Arch (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00424-005-1478-3"}], "href": "https://doi.org/10.1007/s00424-005-1478-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16052353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16052353"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jennifer A Kearney, Yan Yang, Barbara Beyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddl019"}], "href": "https://doi.org/10.1093/hmg/ddl019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16464983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16464983"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Daniel Johnson, Eric S Bennett "}, {"type": "b", "children": [{"type": "t", "text": "Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M605060200"}], "href": "https://doi.org/10.1074/jbc.M605060200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16847056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16847056"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Eric Herlenius, Sarah E Heron, Bronwyn E Grinton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1528-1167.2007.01049.x"}], "href": "https://doi.org/10.1111/j.1528-1167.2007.01049.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17386050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17386050"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ruwei Xu, Evan A Thomas, Misty Jenkins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Neurosci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcn.2007.03.003"}], "href": "https://doi.org/10.1016/j.mcn.2007.03.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17467289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17467289"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joel A Black, Jia Newcombe, Bruce D Trapp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium channel expression within chronic multiple sclerosis plaques."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuropathol Exp Neurol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/nen.0b013e3181462841"}], "href": "https://doi.org/10.1097/nen.0b013e3181462841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17805013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17805013"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Sunita N Misra, Kristopher M Kahlig, Alfred L George "}, {"type": "b", "children": [{"type": "t", "text": "Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1528-1167.2008.01619.x"}], "href": "https://doi.org/10.1111/j.1528-1167.2008.01619.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18479388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18479388"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Vesselin Z Miloushev, Joshua A Levine, Mark A Arbing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Solution structure of the NaV1.2 C-terminal EF-hand domain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M807401200"}], "href": "https://doi.org/10.1074/jbc.M807401200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19129176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19129176"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Fernanda Laezza, Angelika Lampert, Marie A Kozel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Neurosci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcn.2009.05.007"}], "href": "https://doi.org/10.1016/j.mcn.2009.05.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19465131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19465131"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ram Lakhan, Ritu Kumari, Usha K Misra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Clin Pharmacol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2125.2009.03437.x"}], "href": "https://doi.org/10.1111/j.1365-2125.2009.03437.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19694741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19694741"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Evan A Thomas, Roger J Hawkins, Kay L Richards, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heat opens axon initial segment sodium channels: a febrile seizure mechanism?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.21712"}], "href": "https://doi.org/10.1002/ana.21712"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19743470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19743470"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiuyu Shi, Sawa Yasumoto, Eiji Nakagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Dev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.braindev.2009.08.009"}], "href": "https://doi.org/10.1016/j.braindev.2009.08.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19783390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19783390"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "I Ogiwara, K Ito, Y Sawaishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3181b9cebc"}], "href": "https://doi.org/10.1212/WNL.0b013e3181b9cebc"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19786696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19786696"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yunxiang Liao, Liesbet Deprez, Snezana Maljevic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awq057"}], "href": "https://doi.org/10.1093/brain/awq057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20371507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20371507"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sandeep Grover, Mandaville Gourie-Devi, Ruchi Baghel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs.10.62"}], "href": "https://doi.org/10.2217/pgs.10.62"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20602612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20602612"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Nicole A Hawkins, Melinda S Martin, Wayne N Frankel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2010.11.016"}], "href": "https://doi.org/10.1016/j.nbd.2010.11.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21156207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21156207"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Wenze Wang, Sachio Takashima, Yoshie Segawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2011.02.083"}], "href": "https://doi.org/10.1016/j.brainres.2011.02.083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21377452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21377452"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Michael D Feldkamp, Liping Yu, Madeline A Shea "}, {"type": "b", "children": [{"type": "t", "text": "Structural and energetic determinants of apo calmodulin binding to the IQ motif of the Na(V)1.2 voltage-dependent sodium channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2011.02.009"}], "href": "https://doi.org/10.1016/j.str.2011.02.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21439835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21439835"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Stephan J Sanders, Michael T Murtha, Abha R Gupta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De novo mutations revealed by whole-exome sequencing are strongly associated with autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature10945"}], "href": "https://doi.org/10.1038/nature10945"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22495306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22495306"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Federico Zara, Nicola Specchio, Pasquale Striano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/epi.12089"}], "href": "https://doi.org/10.1111/epi.12089"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23360469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23360469"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Marlin Touma, Mugdha Joshi, Meghan C Connolly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole genome sequencing identifies SCN2A mutation in monozygotic twins with Ohtahara syndrome and unique neuropathologic findings."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/epi.12137"}], "href": "https://doi.org/10.1111/epi.12137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23550958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23550958"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Batoul Sadat Haerian, Larry Baum, Patrick Kwan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs.13.104"}], "href": "https://doi.org/10.2217/pgs.13.104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23859570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23859570"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Kazuyuki Nakamura, Mitsuhiro Kato, Hitoshi Osaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3182a43e57"}], "href": "https://doi.org/10.1212/WNL.0b013e3182a43e57"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23935176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23935176"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Larry Baum, Batoul Sadat Haerian, Ho-Keung Ng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-013-1405-1"}], "href": "https://doi.org/10.1007/s00439-013-1405-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24337656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24337656"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Anna-Lena Baasch, Irina Hüning, Christian Gilissen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/epi.12554"}], "href": "https://doi.org/10.1111/epi.12554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24579881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24579881"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Dwight Dickinson, Richard E Straub, Joey W Trampush, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA Psychiatry (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jamapsychiatry.2014.157"}], "href": "https://doi.org/10.1001/jamapsychiatry.2014.157"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24718902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24718902"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Saadet Mercimek-Mahmutoglu, Jaina Patel, Dawn Cordeiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic yield of genetic testing in epileptic encephalopathy in childhood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/epi.12954"}], "href": "https://doi.org/10.1111/epi.12954"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25818041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25818041"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Mingxuan Xu, Edward C Cooper "}, {"type": "b", "children": [{"type": "t", "text": "An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.638932"}], "href": "https://doi.org/10.1074/jbc.M115.638932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25998125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25998125"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Katherine B Howell, Jacinta M McMahon, Gemma L Carvill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0000000000001926"}], "href": "https://doi.org/10.1212/WNL.0000000000001926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26291284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26291284"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Liam S Carroll, Rebecca Woolf, Yousef Ibrahim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychiatr Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/YPG.0000000000000110"}], "href": "https://doi.org/10.1097/YPG.0000000000000110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26555645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26555645"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Alissa M D'Gama, Sirisha Pochareddy, Mingfeng Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2015.11.009"}], "href": "https://doi.org/10.1016/j.neuron.2015.11.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26637798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26637798"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "N Schwarz, A Hahn, T Bast, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00415-015-7984-0"}], "href": "https://doi.org/10.1007/s00415-015-7984-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26645390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26645390"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Natalie Trump, Amy McTague, Helen Brittain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmedgenet-2015-103263"}], "href": "https://doi.org/10.1136/jmedgenet-2015-103263"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26993267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26993267"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "M Saitoh, K Kobayashi, I Ohmori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES/AERRPS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jns.2016.07.040"}], "href": "https://doi.org/10.1016/j.jns.2016.07.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27538648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27538648"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Roy Ben-Shalom, Caroline M Keeshen, Kiara N Berrios, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opposing Effects on Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2017.01.009"}], "href": "https://doi.org/10.1016/j.biopsych.2017.01.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28256214"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28256214"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Markus Wolff, Katrine M Johannesen, Ulrike B S Hedrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awx054"}], "href": "https://doi.org/10.1093/brain/awx054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28379373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28379373"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Xiaojing Pan, Zhangqiang Li, Xiaoshuang Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis for pore blockade of human Na"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " channel Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "v"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.2 by the μ-conotoxin KIIIA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aaw2999"}], "href": "https://doi.org/10.1126/science.aaw2999"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30765605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30765605"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "N Schwarz, T Bast, E Gaily, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical and genetic spectrum of SCN2A-associated episodic ataxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Paediatr Neurol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejpn.2019.03.001"}], "href": "https://doi.org/10.1016/j.ejpn.2019.03.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30928199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30928199"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Emily R Mason, Fenfen Wu, Reesha R Patel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Resurgent and Gating Pore Currents Induced by "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "De Novo SCN2A"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Epilepsy Mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "eNeuro (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/ENEURO.0141-19.2019"}], "href": "https://doi.org/10.1523/ENEURO.0141-19.2019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31558572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31558572"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Christopher H Thompson, Roy Ben-Shalom, Kevin J Bender, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1085/jgp.201912442"}], "href": "https://doi.org/10.1085/jgp.201912442"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31995133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31995133"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Xinran Dong, Bo Liu, Lin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmedgenet-2019-106377"}], "href": "https://doi.org/10.1136/jmedgenet-2019-106377"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32005694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32005694"}]}]}]}
Synonyms BFNIS, EIEE11, SCN2A2, NAC2, NAV1.2, SCN2A1, NA(V)1.2, HBSCII, HBA, BFIC3, BFIS3
Proteins SCN2A_HUMAN
NCBI Gene ID 6326
API
Download Associations
Predicted Functions View SCN2A's ARCHS4 Predicted Functions.
Co-expressed Genes View SCN2A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SCN2A's ARCHS4 Predicted Functions.

Functional Associations

SCN2A has 6,565 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 132 datasets.

Click the + buttons to view associations for SCN2A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by SCN2A gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN2A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN2A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN2A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SCN2A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SCN2A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SCN2A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SCN2A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN2A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SCN2A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with SCN2A gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN2A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SCN2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SCN2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with SCN2A gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with SCN2A gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SCN2A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SCN2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SCN2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SCN2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SCN2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN2A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SCN2A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SCN2A gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SCN2A gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with SCN2A gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SCN2A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving SCN2A gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SCN2A gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with SCN2A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with SCN2A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SCN2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SCN2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SCN2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SCN2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SCN2A protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SCN2A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN2A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SCN2A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SCN2A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SCN2A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SCN2A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SCN2A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SCN2A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SCN2A from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SCN2A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving SCN2A gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SCN2A gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SCN2A gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SCN2A protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SCN2A protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SCN2A protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SCN2A gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SCN2A gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SCN2A gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of SCN2A gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SCN2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SCN2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding SCN2A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with SCN2A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SCN2A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with SCN2A gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SCN2A gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SCN2A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SCN2A protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SCN2A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SCN2A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SCN2A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with SCN2A gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for SCN2A from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP ASCT+B Annotations cell types associated with SCN2A gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with SCN2A gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with SCN2A gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SCN2A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SCN2A protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SCN2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SCN2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SCN2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate SCN2A protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways 2026 pathways involving SCN2A protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with SCN2A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SCN2A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SCN2A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SCN2A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SCN2A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SCN2A protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SCN2A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SCN2A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SCN2A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SCN2A gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for SCN2A from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SCN2A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NURSA Protein Complexes protein complexs containing SCN2A protein recovered by IP-MS from the NURSA Protein Complexes dataset.
NURSA Protein-Protein Interactions interacting proteins for SCN2A from the NURSA Protein-Protein Interactions dataset.
OMIM Gene-Disease Associations phenotypes associated with SCN2A gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SCN2A from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SCN2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SCN2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SCN2A protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SCN2A protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with SCN2A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
Reactome Pathways 2014 pathways involving SCN2A protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SCN2A protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SCN2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SCN2A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SCN2A gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SCN2A gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of SCN2A gene from the Sci-Plex Drug Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with SCN2A gene from the SynGO Synaptic Gene Annotations dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SCN2A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SCN2A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SCN2A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SCN2A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SCN2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SCN2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SCN2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SCN2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SCN2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SCN2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving SCN2A protein from the WikiPathways Pathways 2024 dataset.